Combination DMARD therapy for rheumatoid arthritis: a step closer to the goal.
作者信息
O'Dell J R
出版信息
Ann Rheum Dis. 1996 Nov;55(11):781-3. doi: 10.1136/ard.55.11.781.
Abstract
摘要
相似文献
1
Combination DMARD therapy for rheumatoid arthritis: a step closer to the goal.类风湿关节炎的联合改善病情抗风湿药治疗：向目标又迈进了一步。
Ann Rheum Dis. 1996 Nov;55(11):781-3. doi: 10.1136/ard.55.11.781.
2
Physicians' adherence to tight control treatment strategy and combination DMARD therapy are additively important for reaching remission and maintaining working ability in early rheumatoid arthritis: a subanalysis of the FIN-RACo trial.在早期类风湿关节炎中，医生坚持严格控制治疗策略和联合使用改善病情抗风湿药（DMARD）疗法对于实现病情缓解和维持工作能力具有叠加的重要性：芬兰类风湿关节炎注册研究（FIN-RACo）试验的一项亚组分析
Ann Rheum Dis. 2014 Apr;73(4):788-90. doi: 10.1136/annrheumdis-2013-204271. Epub 2013 Dec 2.
3
Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts.类风湿关节炎中持续停用改善病情抗风湿药缓解的患病率及预测因素：来自两个大型早期关节炎队列的结果
Arthritis Rheum. 2009 Aug;60(8):2262-71. doi: 10.1002/art.24661.
4
Combinations of second-line drugs for rheumatoid arthritis: is remission induction a reasonable goal?类风湿关节炎二线药物联合治疗：诱导缓解是否是一个合理的目标？
Rev Rhum Engl Ed. 1998 Mar;65(3):161-4.
5
Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.早期类风湿关节炎中使用单药或联合改善病情抗风湿药物治疗时治疗开始的延迟及缓解的诱导。
Arthritis Rheum. 2002 Apr;46(4):894-8. doi: 10.1002/art.10135.
6
Sustained DMARD-free remission in subgroups of patients with rheumatoid arthritis: an analysis of two prospective cohorts with early arthritis.类风湿关节炎患者亚组的持续无改善病情抗风湿药缓解：两项早期关节炎前瞻性队列分析
Lancet Rheumatol. 2025 Apr;7(4):e252-e260. doi: 10.1016/S2665-9913(24)00234-0. Epub 2024 Dec 20.
7
Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial.甲氨蝶呤联合逐渐减停糖皮质激素缓解诱导（COBRA Slim）与其他强化治疗策略治疗靶向治疗早期类风湿关节炎的疗效比较：CareRA 随机实用开放标签优效性试验的 1 年结果。
Ann Rheum Dis. 2017 Mar;76(3):511-520. doi: 10.1136/annrheumdis-2016-209212. Epub 2016 Jul 18.
8
Correspondence on 'Tapering towards DMARD-free remission in rheumatoid arthritis'.关于“类风湿关节炎逐渐减药至无改善病情抗风湿药缓解”的通信
Ann Rheum Dis. 2023 Jan;82(1):e9. doi: 10.1136/annrheumdis-2020-219239. Epub 2020 Nov 6.
9
Does the presence of magnetic resonance imaging-detected osteitis at diagnosis with rheumatoid arthritis lower the risk for achieving disease-modifying antirheumatic drug-free sustained remission: results of a longitudinal study.在类风湿关节炎诊断时存在磁共振成像检测到的骨炎是否会降低达到疾病修饰抗风湿药物无持续缓解的风险：一项纵向研究的结果。
Arthritis Res Ther. 2018 Apr 10;20(1):68. doi: 10.1186/s13075-018-1553-8.
10
Induction of remission in rheumatoid arthritis: criteria and opportunities.
Rheumatol Int. 2008 Dec;29(2):131-9. doi: 10.1007/s00296-008-0699-0. Epub 2008 Sep 21.
引用本文的文献
1
Guidelines for the use of conventional and newer disease-modifying antirheumatic drugs in elderly patients with rheumatoid arthritis.老年类风湿关节炎患者使用传统和新型改善病情抗风湿药物的指南。
Drugs Aging. 2009;26(4):273-93. doi: 10.2165/00002512-200926040-00001.
2
Can non-fundable trials be conducted anyway? The case for open, randomised, actively controlled trials in rheumatology.无论如何，是否可以进行无法获得资金支持的试验？关于风湿病领域开放、随机、积极对照试验的情况。
Ann Rheum Dis. 1998 Mar;57(3):128-30. doi: 10.1136/ard.57.3.128.
本文引用的文献
1
Combined therapy of rheumatoid arthritis with gold and chloroquine. I. Evaluation of the therapeutic effect.类风湿关节炎的金制剂与氯喹联合治疗。I. 治疗效果评估。
Acta Rheumatol Scand. 1963;9:48-55.
2
The changing face of therapy for rheumatoid arthritis.
Rheum Dis Clin North Am. 1995 Aug;21(3):845-52.
3
Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications.单独使用甲氨蝶呤、柳氮磺胺吡啶和羟氯喹治疗类风湿性关节炎，或三种药物联合使用。
N Engl J Med. 1996 May 16;334(20):1287-91. doi: 10.1056/NEJM199605163342002.
4
Overview of combination second-line or disease-modifying antirheumatic drug therapy in rheumatoid arthritis.类风湿关节炎二线联合或改善病情抗风湿药物治疗概述
Br J Rheumatol. 1995 Nov;34 Suppl 2:96-9.
5
Combination of sulphasalazine and methotrexate in the management of rheumatoid arthritis--view based on personal clinical experience.柳氮磺胺吡啶与甲氨蝶呤联合治疗类风湿关节炎——基于个人临床经验的观点
Br J Rheumatol. 1995 Nov;34 Suppl 2:109-12.
6
Combination drug therapy of seropositive rheumatoid arthritis.
J Rheumatol. 1995 Sep;22(9):1636-45.
7
Optimizing combination chemotherapy for rheumatoid arthritis.优化类风湿关节炎的联合化疗
Ann N Y Acad Sci. 1993 Nov 30;696:285-91. doi: 10.1111/j.1749-6632.1993.tb17163.x.
8
Combination of methotrexate and sulphasalazine vs methotrexate alone: a randomized open clinical trial in rheumatoid arthritis patients resistant to sulphasalazine therapy.甲氨蝶呤与柳氮磺胺吡啶联合用药对比单独使用甲氨蝶呤：一项针对对柳氮磺胺吡啶治疗耐药的类风湿关节炎患者的随机开放性临床试验。
Br J Rheumatol. 1994 Nov;33(11):1049-55. doi: 10.1093/rheumatology/33.11.1049.
9
Methotrexate in rheumatoid arthritis. A five-year prospective multicenter study.甲氨蝶呤治疗类风湿关节炎。一项为期五年的前瞻性多中心研究。
Arthritis Rheum. 1994 Oct;37(10):1492-8. doi: 10.1002/art.1780371013.
10
The efficacy and toxicity of combination therapy in rheumatoid arthritis. A meta-analysis.联合治疗在类风湿性关节炎中的疗效与毒性：一项荟萃分析。
Arthritis Rheum. 1994 Oct;37(10):1487-91. doi: 10.1002/art.1780371012.
Zotero 插件